Simultaneous Determination of Capmatinib and Resveratrol via Micellar‐Enhanced Synchronized Fluorescence Spectroscopy: Application to Human Plasma and Environmental Water Samples
- 3 June 2026
- journal article
- research article
- Published by Wiley in Luminescence
- Vol. 41 (6) , e70524
Abstract
A novel, eco‐friendly, and highly sensitive synchronous spectrofluorimetric method was developed and validated for the first time to simultaneously determine the synergistic chemotherapy agents, capmatinib (CMT) and resveratrol (RES). The method relies on the native fluorescence characteristics of both drugs, ensuring excellent sensitivity and selectivity without prederivatization. Simultaneous quantification was achieved at 407 nm for CMT and 306 nm for RES with a wavelength difference (∆λ) of 80 nm, using water and 1.5 mL of 1% Kolliphor as a green solvent system. Validation was performed in accordance with ICH guidelines, confirming satisfactory linearity, precision, accuracy, and selectivity. The linear concentration ranges were 50.0–1800.0 and 5.0–100.0 ng/mL for CMT and RES, with detection limits of 11.69 and 1.34 ng/mL, respectively. Owing to its high sensitivity, the developed method was successfully applied to human plasma samples, achieving excellent recovery values of 95.04%–105.54% and 94.60%–104.52% for CMT and RES, respectively, which supports its bioanalytical suitability. Moreover, the method was applied for trace analysis of both drugs in tap water and river water samples with %recoveries of 95.03%–99.14% and 94.34%–101.08% for CMT and RES, respectively. The environmental sustainability along with the operational efficiency of the proposed approach was further assessed.Keywords
This publication has 34 references indexed in Scilit:
- Development of a Novel Synchronous Spectrofluorimetric Method Coupled With Chemometric Modelling for Ultrasensitive Analysis of Tenofovir and Dolutegravir With Implication for Pharmacokinetic StudiesLuminescence, 2025
- Environmentally benign first derivative synchronous spectrofluorimetry for the analysis of two binary mixtures containing duloxetine with avanafil or tadalafil in spiked plasma samplesLuminescence, 2024
- Investigation of micellar enhancement in simultaneous assay of rosuvastatin and amlodipine in their fixed-dose combined tabletsMicrochemical Journal, 2020
- Development and full validation of an LC–MS/MS methodology to quantify capmatinib (INC280) following intragastric administration to ratsBiomedical Chromatography, 2019
- Resveratrol: a review of plant sources, synthesis, stability, modification and food applicationJournal of the Science of Food and Agriculture, 2019
- Sensitive spectrofluorimetric assay based on micelle enhanced protocol for the determination of hepatitis C antiviral agent (simeprevir): Application to dosage form and human plasmaMicrochemical Journal, 2019
- A review of molecular mechanisms involved in anticancer and antiangiogenic effects of natural polyphenolic compoundsPhytotherapy Research, 2019
- Health benefits of resveratrol: Evidence from clinical studiesMedicinal Research Reviews, 2019
- Preclinical Evaluation of MET Inhibitor INC-280 With or Without the Epidermal Growth Factor Receptor Inhibitor Erlotinib in Non–Small-Cell Lung CancerClinical Lung Cancer, 2017
- Micelle‐enhanced spectrofluorimetric method for quantification of entacapone in tablets and human plasmaLuminescence, 2016